Mark Mckenna
Chairman presso APOGEE THERAPEUTICS, INC.
Patrimonio netto: 624 000 $ in data 31/03/2024
Provenienza dei contatti di primo grado di Mark Mckenna
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Bausch & Lomb, Inc.
 Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY.
64
| Subsidiary | Medical Specialties | 64 |
| Subsidiary | Biotechnology | 28 | |
| Public Company | Biotechnology | 19 | |
| Public Company | Biotechnology | 16 | |
Prometheus Laboratories, Inc.
 Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA.
9
| Subsidiary | Pharmaceuticals: Major | 9 |
| Holding Company | Pharmaceuticals: Major | 2 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Mark Mckenna tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| ALLERGAN, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chief Executive Officer General Counsel Human Resources Officer | |
| AMGEN INC. | Pharmaceuticals: Major | Director/Board Member Comptroller/Controller/Auditor | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Director/Board Member Sales & Marketing Corporate Officer/Principal Human Resources Officer | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Investor Relations Contact Corporate Officer/Principal Comptroller/Controller/Auditor | |
| PAYCHEX, INC. | Data Processing Services | Director of Finance/CFO Human Resources Officer Director of Finance/CFO | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal Director/Board Member Chief Executive Officer Investor Relations Contact | |
| STAAR SURGICAL COMPANY | Medical Specialties | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| BRIDGEBIO PHARMA, INC. | Biotechnology | Director/Board Member Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Human Resources Officer Corporate Officer/Principal | |
| ALLERGAN PLC | Pharmaceuticals: Major | Chief Executive Officer Comptroller/Controller/Auditor Public Communications Contact General Counsel Human Resources Officer Sales & Marketing | |
| University of California, Los Angeles | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Masters Business Admin Undergraduate Degree | |
| BAUSCH HEALTH COMPANIES INC. | Pharmaceuticals: Other | Director/Board Member Chief Executive Officer Corporate Officer/Principal Chairman Sales & Marketing | |
| The Wharton School of the University of Pennsylvania | College/University | Graduate Degree Masters Business Admin Masters Business Admin Masters Business Admin | |
| AXCA HEALPAR | Biotechnology | Director/Board Member Director/Board Member General Counsel General Counsel | |
| University of Rochester Simon Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| University of Connecticut | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| Stanford University | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
| BAUSCH + LOMB CORPORATION | Medical Specialties | Chief Executive Officer Chief Executive Officer General Counsel | |
Bausch & Lomb BV
 Bausch & Lomb BV Electronic ComponentsElectronic Technology Bausch & Lomb is the eye health company dedicated to perfecting vision and enhancing life. It offers the world's most comprehensive portfolio of eye health products and the proud that it is one of the oldest, best known and most respected healthcare brands in the world. The company began in 1853 in Rochester, New York, as a small optical shop that grew to become a multi-billion dollar corporation with nearly 14,000 employees worldwide, and with products available in more than 100 countries. | Electronic Components | Chief Executive Officer Director/Board Member Director/Board Member | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
Nestle Health Science SA
 Nestle Health Science SA Pharmaceuticals: OtherHealth Technology Nestle Health Science SA develops nutritional therapies. Its health management services include aging, brain health, chronic medical conditions, critical care and surgery, food allergy, gastro intestinal, metabolic diseases, and obesity pediatrics. The company was founded in 2011 and is headquartered in Vevey, Switzerland. | Pharmaceuticals: Other | Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
| The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin Graduate Degree Graduate Degree | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| University of California, Berkeley | College/University | Doctorate Degree Undergraduate Degree | |
| DIANTHUS THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Origin Biosciences, Inc.
 Origin Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Part of BridgeBio Pharma, Inc., Origin Biosciences, Inc. is an actively managed investment issuer focused on making equity investments in psychedelics industry-related companies to provide investors with diverse exposure to the sector. The private company is based in Palo Alto, CA. The company, led by a team of industry experts, leverages its management expertise, professional network, and due diligence process to identify and invest in leading and emerging companies focused on the emerging psychedelics sector. Michael Henderson has been the CEO of the company since 2018. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| University of California San Diego | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Pennsylvania | College/University | Corporate Officer/Principal Graduate Degree | |
| State University of New York College at Brockport | College/University | Undergraduate Degree Undergraduate Degree | |
| University of California | College/University | Director/Board Member Doctorate Degree | |
QED Therapeutics, Inc.
 QED Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of BridgeBio Pharma, Inc., QED Therapeutics, Inc. is a biotechnology company based in Palo Alto, CA. The private company focuses on precision medicine for FGFR-driven diseases and is committed to finding solutions to FGFR-driven cancers and diseases to give patients more possibilities. QED Therapeutics' lead investigational candidate is infigratinib, an orally administered, FGFR1-3 selective tyrosine kinase inhibitor that has shown activity in patients with chemotherapy-refractory cholangiocarcinoma with FGFR2 fusions and advanced urothelial carcinoma with FGFR3 genomic alterations. In 2020, QED submitted a new drug application (NDA) with the Food and Drug Administration for second- and later-line cholangiocarcinoma. Michael Henderson has been the CEO of the company since 2017. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Corporate Officer/Principal Undergraduate Degree | |
| INVIVYD, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
| College of Charleston | College/University | Undergraduate Degree Undergraduate Degree | |
| ARYA SCIENCES ACQUISITION CORP IV | Founder Director/Board Member | ||
| Harvard Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| Purdue University | College/University | Undergraduate Degree Graduate Degree | |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Director/Board Member Doctorate Degree | |
SwanBio Therapeutics, Inc.
 SwanBio Therapeutics, Inc. BiotechnologyHealth Technology SwanBio Therapeutics, Inc. operates as a gene therapy firm. The company was founded by Tom Anderson, Rachel Salzman, Karen Kozarsky and Florian S. Eichler and is headquartered in Bala Cynwyd, PA. | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| San Diego State University | College/University | Undergraduate Degree Undergraduate Degree | |
| Columbia Business School | College/University | Masters Business Admin Masters Business Admin |
Statistiche
Distribuzione geografica
| Stati Uniti | 44 |
| Svizzera | 3 |
| Irlanda | 2 |
| Canada | 2 |
| Paesi Bassi | 2 |
Settori
| Health Technology | 26 |
| Consumer Services | 22 |
| Technology Services | 2 |
| Commercial Services | 2 |
| Electronic Technology | 2 |
Posizioni
| Director/Board Member | 459 |
| Corporate Officer/Principal | 221 |
| Independent Dir/Board Member | 140 |
| Chief Executive Officer | 98 |
| President | 95 |
Contatti più connessi
| Insiders | |
|---|---|
| Brenton Saunders | 38 |
| Anne Michelle Whitaker | 35 |
| Ambrose Bailey | 32 |
| Bihua Chen | 32 |
| Fred Hassan | 29 |
| Joseph Papa | 28 |
| Domenico de Sole | 28 |
| Scott Glenn | 28 |
| Linda Rice | 27 |
| John Schmid | 24 |
| Jane Henderson | 24 |
| Alison Lawton | 24 |
| James Lightman | 22 |
| Robert Grant | 21 |
| Paul Friedman | 21 |
- Borsa valori
- Insiders
- Mark Mckenna
- Connessioni Società
